Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jul 9;93(14):7375-80.
doi: 10.1073/pnas.93.14.7375.

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects

Affiliations

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects

D K Rohrer et al. Proc Natl Acad Sci U S A. .

Abstract

At least three distinct beta-adrenergic receptor (beta-AR) subtypes exist in mammals. These receptors modulate a wide variety of processes, from development and behavior, to cardiac function, metabolism, and smooth muscle tone. To understand the roles that individual beta-AR subtypes play in these processes, we have used the technique of gene targeting to create homozygous beta 1-AR null mutants (beta 1-AR -/-) in mice. The majority of beta 1-AR -/- mice die prenatally, and the penetrance of lethality shows strain dependence. Beta l-AR -/- mice that do survive to adulthood appear normal, but lack the chronotropic and inotropic responses seen in wild-type mice when beta-AR agonists such as isoproterenol are administered. Moreover, this lack of responsiveness is accompanied by markedly reduced stimulation of adenylate cyclase in cardiac membranes from beta 1-AR -/- mice. These findings occur despite persistent cardiac beta 2-AR expression, demonstrating the importance of beta 1-ARs for proper mouse development and cardiac function, while highlighting functional differences between beta-AR subtypes.

PubMed Disclaimer

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1982 Sep;320(3):240-5 - PubMed
    1. J Biol Chem. 1995 Nov 10;270(45):27235-43 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):193-202 - PubMed
    1. Nature. 1986 May 1-7;321(6065):75-9 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):406-9 - PubMed

Publication types

MeSH terms